Convalescent Plasma Antibody Levels and Covid-19

Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19) under the presumption that such plasma contains potentially therapeutic antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can be passively transferred to the plasma recipient. Dr. Michael Joyner discusses whether convalescent plasma with high antibody levels rather than low antibody levels is associated with a lower risk of death.

Image courtesy of Michael Joyner

Image courtesy of interviewee

Leave a Reply

Your email address will not be published.

×
Log-in or Sign-up to Faculti
Currently viewing as guest. You have insight(s) remaining for this month.
Copyright © Faculti Media Limited 2023. All rights reserved.
Recommend Faculti to your librarian

error: